Investors

We focus on driving sustainable growth today while reinvesting for the future, creating value for shareholders and society.

  • 7% organic sales growth and a 37.9% adjusted EBITDA margin for Novonesis in the first nine months of 2026.

    Latest results

    Our interim report for the first nine months was released on November 5, 2026.

  • Man-diving-into-wave

    Upcoming event

    On December 11, 2026 at 14:00 CET, we will conduct a conference call where we share insights about the Food & Beverages business besides Dairy, its growth drivers and Novonesis' role and position.

image

Why invest in Novonesis

Explore how biosolutions drive long-term value for our investors.

  • Novonesis GROW strategy key visual

    Our strategy

    Our 2030 GROW strategy focuses on growing our core business while reinvesting for the future.

  • three-generations-of-family

    Sustainable investing

    Investing in Novonesis means contributing to a sustainable future through the power of biosolutions.

  • Man diving in

    Spotlight educational sessions

    Dive into our educational sessions to learn more about our different businesses.

Contact investor relations

We encourage all shareholders and investment professionals to contact us, should you have any questions or requests concerning Novonesis.